CoChat

Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis

Open access
Barra, Fabio, Scala, Carolina, Ferrero, Simone · 2018 · Expert Opinion on Drug Metabolism & Toxicology

The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Endometriosis is a chronic estrogen and progestogen responsive inflammatory disease associated with pain symptoms and infertility. The medical therapy of endometriosis aims to induce decidualization within the hormonally dependent ectopic endometrium, and it is often administered to ameliorate women' pain symptoms or to prevent post-surgical disease recurrence. A variety of progestins have been used in monotherapy for the medical management of women with endometriosis. Areas covered: This review aims to offer the reader a complete overview of pharmacokinetic (PK) and clinical efficacy of progestins for the treatment of endometriosis. Expert opinion: Each progestin has a distinct PK parameters and pharmacodynamics affinity not only for progesterone receptor, but also for other steroid receptors, such as estrogen, androgen, and glucocorticoid. Moreover, progestins can also be delivered in different formulations. All these characteristics influence their final biological effect. Randomized, controlled, non-blinded studies support the use of oral progestin-only treatment for pelvic pain associated with endometriosis. Currently, the only two progestins approved by Food and Drug Administration (FDA) for the treatment of endometriosis are norethindrone acetate (NETA) and depot medroxyprogesterone acetate (DMPA).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/17425255.2018.1461840

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 125 references

Research works printed but not linked: 10

  1. Moran C, 1996, Arch Med Res, 27, 535
  2. Ponpuckdee J, 2005, J Med Assoc Thai, 88, S7
  3. Roland M, 1976, J Reprod Med, 17, 249
  4. Moghissi KS, 1976, Obstet Gynecol, 47, 265
  5. Luciano AA, 1988, Obstet Gynecol, 72, 323
  6. 10.1080/j.1600-0412.2001.800708.x · DOI
  7. Brown J, 2012, Cochrane Database Syst Rev, CD002122
  8. Lang J, 2017, J Womens Health (Larchmt)
  9. Vercellini P, 2015, Fertil Steril
  10. Strowitzki T, 2015, Int J Women’s Health, 7, 391

Cited by

See all 100

Metadata

Authors
Barra, F., Scala, C., & Ferrero, S.
Affiliations
Ospedale Policlinico San Martino (IT)
Corresponding author
Ferrero, Simone
Venue
Expert Opinion on Drug Metabolism & Toxicology
Published
2018-04-03
Volume
14
Issue
4
Pages
399-415
ISSN
  • 1742-5255 (ISSN-L)
  • 1744-7607
OpenAlex
W2795797649
Cited by
100
References
119
Citations by year
2026: 8 · 2025: 7 · 2024: 10 · 2023: 26 · 2022: 15 · 2021: 14 · 2020: 11 · 2019: 4 · 2018: 5
FWCI
1.29
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Reproductive Health and Contraception
Keywords
endometriosis, progestins, pharmacokinetics, pharmacodynamics, pelvic pain, norethindrone acetate, depot medroxyprogesterone acetate, progesterone receptor, drug formulation, drug safety
MeSH terms
Norethindrone Acetate, Administration, Oral, Endometriosis, Female, Humans, Norethindrone, Progestins, Receptors, Steroid, Randomized Controlled Trials as Topic, Medroxyprogesterone Acetate, Pelvic Pain

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. https://app.cochat.ai/papers/10.1080/17425255.2018.1461840
The paper
Barra, F., Scala, C., & Ferrero, S. (2018). Current understanding on pharmacokinetics, clinical efficacy and safety of progestins for treating pain associated to endometriosis. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1080/17425255.2018.1461840

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.